Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

We have updated our Rayno Biopharmaceuticals Portfolio with total returns from inception 3/9/09 to 3/30/12.

  • Biggest winners are Alexion (ALXN) Biogen (BIIB) , Cubist (CBST), Regeneron (REGN) and Viropharma (VPHM)-all over 200%. Over the same period the IBB ETF was up 75%.
  • Losers were Albany Molecular (AMRI) down 40% and Gilead (GILD) down 4%.
  • The ten year high for the IBB was this quarter at $124.66. The biotech bull market is intact but hedging should be considered or some profits taken.
  • Over 3 Years the Fidelity Biotechnology Fund (FBIOX) is up 20.76% annualized.
  • Biopharmaceutical stocks have outperformed tools and diagnostic stocks.We will review our Diagnostics/Tools Portfolio next week.

For more details see our Guide to Biotechnology Investing as published in Investor Uprising on May 27, 2011.

2012 PriceOriginalPPrice%RetPricePrice% Ret
Summary Jy'10Recomm Dec'102010Apr'113/30/12Tot
AlexionALXN50.452/2/093580.6130100.892.86530
Albany MolAMRI 2/10/114.68added4.322.78-40
AstexASTXtrade12/27/111.63 1.8614
AmgenAMGN51.72/2/095554.905467.824
BiogenBIIB49.422/2/0948.567.13773.25126.41260
CephalonCEPH55.952/2/0976.561.7-1976.9280.1830
CubistCBST20.72/2/0921.521.4-328.3543.51200
DendreonDNDNtrade11/15/118 10.5237++
ExelixisEXELtrade9/2/103.38.2114811.125.257++
First TrustFBT30.44/15/1037.539.1341.342.1813
GileadGILD34.92/2/095136.2-2942.8148.8-4
iShares ETFIBB76.62/2/0970.593.432101.1123.5875
MicrometMITI6.282/2/0948.121035.4610.91272
ImmunoGenIMGNNew12/22/1112.4 13.912
OptimerOPTR 2/18/1111.8added13.813.9418
RegeneronREGN21.62/2/0917.532.88245.43116.44662
Seattle Gen.SGEN11.852/2/099.5155715.7220.48215
ViroPharmaVPHM10.882/2/091217.34420.0530.1251

Disclosure: I am long AMRI, ASTX, CBST. I am trading some of these stocks and act as an advisory in biotechnology.

About this author: